Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
17.95B | 17.62B | 16.51B | 15.47B | 8.79B | 8.20B | Gross Profit |
2.27B | 2.21B | 1.97B | 1.73B | 1.39B | 1.46B | EBIT |
509.00M | 496.00M | 264.00M | 103.00M | 417.00M | 557.00M | EBITDA |
809.00M | 762.00M | 766.00M | 732.00M | 655.00M | 819.00M | Net Income Common Stockholders |
-255.00M | -309.00M | -128.00M | -576.00M | 247.00M | 467.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.23B | 976.00M | 826.00M | 810.00M | 1.25B | 2.17B | Total Assets |
31.61B | 33.25B | 31.40B | 30.52B | 28.57B | 13.01B | Total Debt |
4.96B | 4.66B | 3.70B | 3.69B | 2.93B | 1.64B | Net Debt |
2.76B | 3.68B | 2.87B | 2.88B | 1.68B | -537.00M | Total Liabilities |
26.51B | 24.48B | 22.29B | 21.49B | 19.45B | 9.68B | Stockholders Equity |
5.01B | 8.67B | 9.00B | 8.91B | 9.04B | 3.27B |
Cash Flow | Free Cash Flow | ||||
414.00M | -567.00M | 175.00M | -1.00B | -720.00M | 202.00M | Operating Cash Flow |
957.00M | -82.00M | 606.00M | -577.00M | -455.00M | 476.00M | Investing Cash Flow |
136.00M | -431.00M | -478.00M | -443.00M | -1.94B | -368.00M | Financing Cash Flow |
-26.00M | 696.00M | -61.00M | 558.00M | 1.46B | -1.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $12.48B | 33.89 | 16.35% | 0.49% | 4.96% | 8.41% | |
78 Outperform | $16.65B | 28.31 | 37.81% | 0.29% | 31.47% | 64.96% | |
76 Outperform | $12.89B | 90.02 | 9.09% | ― | 3.20% | ― | |
75 Outperform | $11.69B | 26.15 | 16.15% | 1.47% | 0.78% | -8.42% | |
71 Outperform | $9.03B | 16.58 | 12.27% | 2.30% | -1.04% | -21.80% | |
64 Neutral | $4.43B | 12.01 | 5.16% | 249.23% | 4.03% | -11.73% | |
56 Neutral | $9.91B | 65.11 | 1.53% | 0.96% | 7.89% | -135.76% |